Magazine Article | July 3, 2023

Ways To Face New Bio Funding & Banking Risks

Source: Life Science Leader

By Wayne Koberstein, Executive Editor, Life Science Leader magazine
Follow Me On Twitter @WayneKoberstein

Funding bio startups has never been easy, but there’s no doubt that it just got harder. We wanted to find at least one company to talk about how it is handling the damage and aftermath of recent bank closures and other cash crunches, and we actually found two. Lisa Ricciardi, CEO of Cognition Therapeutics, and Allan Shaw, CFO of Portage Biotech, here share their views, knowledge, and advice on ways to manage this new funding challenge.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader